Furthermore, over 90% of basal-like breast cancers (triple-negative, high-grade breast carcinomas) have a deleterious TP53 mutation and exhibit a molecular phenotype reminiscent of BRCA1-deficient breast cancer [54]. The gene discussed is TP53; the disease is breast cancer.